Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.980
-0.160 (-7.48%)
At close: May 12, 2025, 4:00 PM
1.990
+0.010 (0.51%)
After-hours: May 12, 2025, 7:05 PM EDT
CELZ Market Cap
CELZ has a market cap or net worth of $232.33 million as of May 12, 2025. Its market cap has increased by 3,474.36% in one year.
Market Cap
232.33M
Enterprise Value
244.59M
1-Year Change
3,474.36%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since December 11, 2017, CELZ's market cap has increased from $2.70M to $232.33M, an increase of 8,504.95%. That is a compound annual growth rate of 82.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 5.50M | 37.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | 0.63% |
| Dec 31, 2020 | 16.00M | 2,185.71% |
| Dec 31, 2019 | 700.00K | -91.03% |
| Dec 31, 2018 | 7.80M | 457.14% |
| Dec 29, 2017 | 1.40M | -48.15% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |